Sandra Weintraub, PhD Clinical Core Leader and Professor

Similar documents
Form D1: Clinician Diagnosis

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

! slow, progressive, permanent loss of neurologic function.

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Form A3: Subject Family History

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

Research on Primary Progressive Aphasia: What It Is Teaching Us About Brain Function and Progression

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

I do not have any disclosures

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Frontotemporal dementia:

FTD basics! Etienne de Villers-Sidani, MD!

Clinical Genetics & Dementia

Early Onset Dementia From the background to the foreground

Dementia Past, Present and Future

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Paper Title Theme Presentation Type Poster Presentatio n Day

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

HIV and Brain Func.on. Tristan J Barber Research Physician St Stephen s AIDS Trust Chelsea and Westminster Hospital

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012

What is. frontotemporal. address? dementia?

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Presenter Disclosure Information. I have no financial relationships to disclose:

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

Minnesota Cognitive Acuity Screen (MCAS) Cognitive screening for mortality risk assessment

FTD/PPA Caregiver Education Conference March 11, 2011

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

Biomarkers: Translating Research into Clinical Practice

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

2016 Programs & Information

Non Alzheimer Dementias

Mild Cognitive Impairment

CNADC. S. Weintraub, CNADC, Northwestern FSM, 2011 DO NOT COPY OR DISTRIBUTE WITHOUT AUTHORʼS PERMISSION

LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders

Assisted Living s Whole Brain Fitness: Can It Prevent Re-hospitalization?

Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration

MCI of the FTLD type: Clinical Features and Imaging and Molecular Biomarkers

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY

Imaging of Alzheimer s Disease: State of the Art

What is primary progressive aphasia?

4/28/2017. Aging with Down Syndrome. Second Annual USC UCEDD Community Education Conference May 19, 2017

Diagnosis and Treatment of Alzhiemer s Disease

LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders. National Institute on Aging National Institutes of Health

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

What is frontotemporal dementia?

Frontotemporal Degeneration

Confronting the Clinical Challenges of Frontotemporal Dementia

Dementia. Assessing Brain Damage. Mental Status Examination

FTD: Improving Outcomes & Outreach

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

Differential Diagnosis

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Dementia is not normal aging!

Dementia and Healthy Ageing : is the pathology any different?

Cogni&ve assessment workshop. Dr. Roger Ho Consultant Psychiatrist and Assistant Professor Department of Psychological Medicine NUHS

Diagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology

The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA

The genetics and neuropathology of frontotemporal lobar degeneration

Overview of the non-alzheimer Dementias

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

NACC Minimum Data Set (MDS) Public Data Element Dictionary

The Aging Brain The Aging Brain

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Chemo Brain and Fa.gue Chemotherapy Related Cogni:ve Impairment Chemotherapy Related Fa:gue. Alok Pant, MD Northwestern Medicine

Mental Health Rotation Educational Goals & Objectives

Alzheimer s Disease Neuroimaging Initiative

Alzheimer s Management: A Technical Solution for Neurologists, Patients and Caregivers

Alzheimer s Disease and Demen<a

Key emerging issues in frontotemporal dementia

Psychiatric Symptom Burden in Elders with HIV-Associated Neurocognitive Disorders

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

Frontotemporal Degeneration

Brain imaging for the diagnosis of people with suspected dementia

Alzheimer s Disease. Stanford Center for Memory Disorders MEDICINE

ApoE, Brain Networks and Behavior: A Cautionary Tale

Molecular Imaging and the Brain

Behavioural variant frontotemporal dementia with dominant gait disturbances case report

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

1 in 3 seniors dies with Alzheimer s or another dementia.

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

Transcription:

Sandra Weintraub, PhD Clinical Core Leader and Professor Northwestern Cognitive Neurology and Alzheimer s Disease Center (CNADC) Chicago, Illinois www.brain.northwestern.edu Why is it so difficult to diagnose demen3a due to frontotemporal lobar degenera3on (FTLD)? 1. There are no tests (biomarkers) for FTLD in blood or other 3ssue 2. Many diseases can cause the same demen3a- no one-to-one rela3onship between symptoms disease 3. To date, the only defini&ve test for presence of a par3cular disease is post mortem brain autopsy to show the specific cellular abnormality 1

DEFINITIONS 1. Frontotemporal Lobar Degenera8on (FTLD) A group of diseases in the brain that cause neurodegenera3on (loss of brain cells): Tauopathy (Pick s disease, cor3cobasal degenera3on, progressive supranuclear palsy) TDP-43 proteinopathy FUS-opathy (rare) 2. Frontotemporal Demen8a (Disorder) The deteriora3on of personality and/or language and/or motor func3ons caused by FTLDs EVALUATIONS TO DEFINE THE DEMENTIA SYMPTOMS Clinical Neuropsychology Evalua8on: What abili8es are abnormal and by how much? Cogni8ve Neurology Evalua8on: What other motor and sensory symptoms are there? What do the medical tests mean? Psychiatry Evalua8on: Are symptoms psychiatric in nature? Can symptoms be controlled with medica8ons? PROCEDURES TO IDENTIFY THE DEMENTIA CAUSE Blood Tests Structural Neuroimaging (CT, MRI scans) Func3onal Neuroimaging (FGD-PET scans) Biomarker imaging (Amyoid PET, tau PET scans) Electroencephalography (EEG) Electromyography (EMG) Cerebrospinal fluid analysis Gene3c tests DIFFERENTIAL DIAGNOSIS What is possibly causing the dementia? 2

Demen&a Types Associated with Frontotemporal Lobar Degenera&ons Behavioral Variant Frontotemporal Demen8a BvFTD Ini8al Signs: Progressive Behavior/ Personality abnormaliies Primary Progressive Aphasia PPA Ini8al Signs: Progressive abnormality of Language PPA Subtypes: Seman&c NonFluentAgramma&c Logopenic Cor8cobasal Syndrome (CBS) Progressive Supranuclear Palsy (PSP) Amyotrophic Lateral Sclerosis (ALS) Ini8al Signs: Progressive abnormality of Motor Func8ons/ Movement DEFINE THE DEMENTIA TYPE 1. Clinical Neuropsychological Evalua3on Clinical Neuropsychologist (PhD): Administers and interprets objec3ve tests of thinking abili3es and behavior in comparison to standards for age and educa3on Is there decline? How much? What is the demen,a type (aphasia, memory, language?) Recommenda3ons for care based on assessment 3

DEFINE THE DEMENTIA TYPE 2. Cogni3ve Neurology Examina3on Cogni3ve Neurologist (MD) Examines visual, auditory, somatosensory and motor symptoms to iden3fy related neurological deficits Interprets findings of medical tests and combines them with results of neurological examina3on. Recommends medica3ons, other treatment DEFINE THE DEMENTIA TYPE 3. Psychiatric Examina3on Psychiatrist (MD) clarifies the diagnosis of symptoms that can be psychiatric in origin (e.g., bvftd symptoms are some3mes diagnosed as a mid-life crisis. ) Recommend medica3ons to manage symptoms (e.g., depression, delusions, hallucina3ons, paranoia, obsessive compulsive behaviors, insomnia, agita3on) 4

IDENTIFY THE CAUSE OF THE DEMENTIA 4. Laboratory Tests: Blood Tests: are there abnormali3es in the blood that can cause the brain to malfunc3on? Structural Neuroimaging (CT, MRI): Exclude other causes of dysfunc3on: strokes, brain tumors. FTLD is not visible but pa_erns of brain shrinkage (atrophy) can help diagnosis. Func8onal Neuroimaging (FGD-PET): measures brain ac3vity/metabolism. Biomarker imaging available for Alzheimer s disease: Amyoid PET shows amyloid in the brain; tau PET is under development IDENTIFY THE CAUSE OF THE DEMENTIA 4. Laboratory Tests: Electroencephalography (EEG): exclude seizures as a cause a demen3a. Mad cow disease is associated with a specific wave disturbance on EEG. Electromyography (EMG): detect abnormal electrical signals in the muscles associated with ALS (Lou Gehrig s disease) CSF tests to exclude infec3on, cancer, other; amyloid and tau test for Alzheimer s disease 5

IDENTIFY THE CAUSE OF THE DEMENTIA 5. GENETICS/INHERITABILITY 30-50% report family history; the rest are sporadic Gene3c Muta3ons: MAPT, chromosome 17 (Tauopathy) GRN (progranulin) (TDP-43 proteinopathy) C9orf72(TDP-43 proteinopathy) TBK1, VCP, CHMP2B less common Gene3c Risk Factors TMEM106B A Case Example : Sally was 48 when her family first no3ced that she was behaving oddly. Obsessively talking about her mother who had been ins3tu3onalized when she was 16 and had died in her 60 s. Brought to a psychiatrist who ini3ally diagnosed depression due to the early loss of her mother. 6

Symptoms progressed over the next 2 years: Worked on assembly line and let items slip past without doing her job Started abusing alcohol and walking about town drunk (extremely uncharacteris3c) Wasn t interested in her children and didn t talk to them when they came home from school (extremely uncharacteris3c) Stopped managing usual household tasks Neuropsychological assessment showed normal memory test scores! BUT Unable to focus her a_en3on: got up from her chair onen, without purpose, and wandered about the office Unable to reason about simple problems Diagnosed with bvftd, predicted to be caused by one of the FTLDs 7

Behavioral Variant Frontotemporal Dementia (BvFTD) Pathology: NON ALZHEIMER- non specific (1980) www.brain.northwestern.edu 8